Considering the significance in this finding, the authors recommended that the AR be considered as one of three prognostic markers to classify breast cancers as triple-positive (ER, HER2, and AR-expressing) or triple-negative (ER, HER2, and AR-negative). The gene discussed is ESR1; the disease is breast cancer.